A new study led by NYU Langone Health researchers has found that cancer cells are better able to resist treatments when they ...

Cancer cells frequently develop the ability to expel anticancer drugs before they can work—a phenomenon called multidrug resistance (MDR)—which is one of the leading reasons why chemotherapy fails in ...

Researchers from The University of Texas MD Anderson Cancer Center have discovered that some cancer cells express the YAP1 ...

Cancer immunotherapy is built on a simple but powerful idea: the immune system can recognize and destroy cancer cells if it is properly activated. In many patients, however, this response is too weak ...

Less than 1 percent of cancers start in the heart, and disease that begins elsewhere seldom spreads to the blood-pumping ...

Scientists discovered that inhibiting the enzyme STK17B forces multiple myeloma cells into iron-driven death and makes therapies more effective. Early mouse studies show strong potential for a new ...

Cancer cells can disarm the immune system not just by hiding from it, but by actively reprogramming nearby immune cells into ...

Since scientists first discovered that human immune cells could be modified to become cancer-fighting agents, they’ve been trying to engineer a cell that’s effective against solid tumors, which ...

T cells are crucial components of our immune system, serving as critical protectors against infection and disease.

Scientists at UCLA have developed an "off-the-shelf" cell-based immunotherapy that was able to track down and kill pancreatic cancer cells even after they had spread to other organs. In a mouse study, ...

Below are summaries of recent Fred Hutch Cancer Center research findings, patient stories and other news. May is the awareness month for skin and bladder cancers, melanoma and mental health. To ...